Biomarkers In Medicine

杂志介绍

Biomarkers In Medicine杂志介绍

《Biomarkers In Medicine》是一本以English为主的未开放获取国际优秀期刊，中文名称医学生物标志物，本刊主要出版、报道医学-MEDICINE, RESEARCH & EXPERIMENTAL领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.9，最新CiteScore 指数为3.8。

本刊近期中国学者发表的论文主要有：

• Association of TLR4 and TLR9 gene polymorphisms with the risk and progression of cervical lesions in HPV-infected women

  Author: Zhang, Chunlin; Yang, Zhiping; Luo, Ping; Ye, Mengxia; Gong, Ping; Gong, Quan; Mei, Bing

• Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma

  Author: Sun, Xiaoqing; Cao, Jianghua; Sun, Peng; Yang, Hang; Li, Huan; Ma, Wenjuan; Wu, Xianqiu; He, Xiaohua; Li, Jing; Li, Zhiming; Huang, Jiajia

• Low expression of MEOX2 is associated with poor survival in patients with breast cancer

  Author: Wang, Huxia; Tang, Yanan; Wang, Meixia; Zhao, Jing; Ding, Caixia; Yang, Xiaomin; Han, Pihua; Liu, Peijun

• Association between CYP19A1 rs6493497 and rs936306 polymorphisms and depression susceptibility in the Chinese population

  Author: Peng, Qiuju; Yan, Yuan; Yan, Huacheng; Xie, Guibo; Shi, Lei; Wen, Yuguan; Chang, Qingxian

英文介绍

Biomarkers In Medicine杂志英文介绍

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.